Schedule 13G ownership disclosure

LYELL IMMUNOPHARMA INC

Security class unavailable · CUSIP: 55083R104

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-041763
Form type
SC 13G
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub